Healthcare provider profile · identity verified

William Matthew Skewes, MD

Internal Medicine · DUBLIN, VA · NPI 1902820764

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	535	114
Alprazolam	Alprazolam	475	67
Methylprednisolone	Methylprednisolone	384	212
Losartan Potassium	Losartan Potassium	363	88
Glimepiride	Glimepiride	350	62
Pantoprazole Sodium	Pantoprazole Sodium	346	90
Lisinopril	Lisinopril	327	86
Gabapentin	Gabapentin	322	59
Amlodipine Besylate	Amlodipine Besylate	283	69
Hydrochlorothiazide	Hydrochlorothiazide	280	66
Simvastatin	Simvastatin	274	72
Trazodone Hcl	Trazodone Hcl	251	49
Metoprolol Succinate	Metoprolol Succinate	241	62
Atorvastatin Calcium	Atorvastatin Calcium	227	59
Rosuvastatin Calcium	Rosuvastatin Calcium	213	63
Azithromycin	Azithromycin	203	132
Escitalopram Oxalate	Escitalopram Oxalate	197	38
Tamsulosin Hcl	Tamsulosin Hcl	183	46
Metformin Hcl Er	Metformin Hcl	181	41
Metformin Hcl	Metformin Hcl	177	44
Famotidine	Famotidine	175	45
Omeprazole	Omeprazole	165	38
Metoprolol Tartrate	Metoprolol Tartrate	163	39
Furosemide	Furosemide	160	35
Eliquis	Apixaban	159	27
Cefuroxime	Cefuroxime Axetil	155	103
Sertraline Hcl	Sertraline Hcl	153	35
Tramadol Hcl	Tramadol Hcl	151	25
Allopurinol	Allopurinol	139	30
Fluticasone Propionate	Fluticasone Propionate	134	57
Ozempic	Semaglutide	127	18
Warfarin Sodium	Warfarin Sodium	121	17
Fluoxetine Hcl	Fluoxetine Hcl	120	26
Potassium Chloride	Potassium Chloride	120	23
Zolpidem Tartrate	Zolpidem Tartrate	109	13
Clonazepam	Clonazepam	107	21
Carvedilol	Carvedilol	106	18
Donepezil Hcl	Donepezil Hcl	99	19
Pravastatin Sodium	Pravastatin Sodium	99	29
Celecoxib	Celecoxib	95	18
Cephalexin	Cephalexin	95	66
Promethazine Hcl	Promethazine Hcl	94	20
Azelastine Hcl	Azelastine Hcl	92	44
Albuterol Sulfate Hfa	Albuterol Sulfate	91	32
Clopidogrel	Clopidogrel Bisulfate	84	20
Temazepam	Temazepam	83	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	81	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	78	15
Prednisone	Prednisone	72	23
Bupropion Xl	Bupropion Hcl	71	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	71	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	70	13
Ondansetron Odt	Ondansetron	70	25
Meclizine Hcl	Meclizine Hcl	67	22
Methocarbamol	Methocarbamol	62	suppressed
Fluconazole	Fluconazole	60	25
Lorazepam	Lorazepam	60	13
Jardiance	Empagliflozin	59	12
Synthroid	Levothyroxine Sodium	59	15
Atenolol	Atenolol	58	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	14
Spironolactone	Spironolactone	55	15
Citalopram Hbr	Citalopram Hydrobromide	48	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	48	13
Diazepam	Diazepam	47	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	43	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	43	26
Meloxicam	Meloxicam	43	11
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	42	18
Ketoconazole	Ketoconazole	42	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Memantine Hcl	Memantine Hcl	41	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	41	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	28
Mupirocin	Mupirocin	40	19
Valacyclovir	Valacyclovir Hcl	40	suppressed
Montelukast Sodium	Montelukast Sodium	39	12
Finasteride	Finasteride	36	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	35	11
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Ibuprofen	Ibuprofen	34	suppressed
Nystatin	Nystatin	34	12
Buspirone Hcl	Buspirone Hcl	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Baclofen	Baclofen	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Trulicity	Dulaglutide	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Lansoprazole	Lansoprazole	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	22
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	14
Xarelto	Rivaroxaban	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Colestipol Hcl	Colestipol Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Dexlansoprazole Dr	Dexlansoprazole	23	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Amoxicillin	Amoxicillin	22	11
Ezetimibe	Ezetimibe	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Butalbital-Acetaminophen	Butalbital/Acetaminophen	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	20	suppressed
Colchicine	Colchicine	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	14
Cefdinir	Cefdinir	17	13
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Silodosin	Silodosin	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Armour Thyroid	Thyroid,pork	14	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	14	suppressed
Estradiol	Estradiol	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Np Thyroid	Thyroid,pork	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Zonisamide	Zonisamide	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Desloratadine	Desloratadine	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Ssd	Silver Sulfadiazine	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Telmisartan-Amlodipine	Telmisartan/Amlodipine	12	suppressed
Topiramate	Topiramate	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Byetta	Exenatide	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Propylthiouracil	Propylthiouracil	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error